The DOI matches its Crossref record; 159 of the 159 references it cites were found in a registry or an index.
Therapies targeting cancer stem cells: Current trends and future challenges
Open accessAbstract
Traditional therapies against cancer, chemo- and radiotherapy, have multiple limitations that lead to treatment failure and cancer recurrence. These limitations are related to systemic and local toxicity, while treatment failure and cancer relapse are due to drug resistance and self-renewal, properties of a small population of tumor cells called cancer stem cells (CSCs). These cells are involved in cancer initiation, maintenance, metastasis and recurrence. Therefore, in order to develop efficient treatments that can induce a long-lasting clinical response preventing tumor relapse it is important to develop drugs that can specifically target and eliminate CSCs. Recent identification of surface markers and understanding of molecular feature associated with CSC phenotype helped with the design of effective treatments. In this review we discuss targeting surface biomarkers, signaling pathways that regulate CSCs self-renewal and differentiation, drug-efflux pumps involved in apoptosis resistance, microenvironmental signals that sustain CSCs growth, manipulation of miRNA expression, and induction of CSCs apoptosis and differentiation, with specific aim to hamper CSCs regeneration and cancer relapse. Some of these agents are under evaluation in preclinical and clinical studies, most of them for using in combination with traditional therapies. The combined therapy using conventional anticancer drugs with CSCs-targeting agents, may offer a promising strategy for management and eradication of different types of cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Daniele, S., Costa, B., Zappelli, E., Pozzo, E. D., Sestito, S., Nesi, G., Campiglia, P., Marinelli, L., Novellino, E., Rapposelli, S., et al. (2015) · Scientific Reports · doi:10.1038/srep09956 · Cited by 102
RetractedProspective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Bonnet, D., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 5,864
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
Shared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,494
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Tumour stem cells and drug resistance
Dean, M., Fojo, T., & Bates, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1590 · Cited by 3,668
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,339
Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.
Goodell, M. A., Brose, K., Paradis, G., Conner, A. S., & Mulligan, R. C. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1797 · Cited by 2,903
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,389
Efficient tumour formation by single human melanoma cells
Quintana, E., Shackleton, M., Sabel, M. S., Fullen, D. R., Johnson, T. M., & Morrison, S. J. (2008) · Nature · doi:10.1038/nature07567 · Cited by 1,796
Majeti, R., Chao, M. P., Alizadeh, A. A., Pang, W. W., Jaiswal, S., Gibbs, K. D., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.045 · Cited by 1,752
Willingham, S. B., Volkmer, J.-P., Gentles, A. J., Sahoo, D., Dalerba, P., Mitra, S. S., Wang, J., Contreras-Trujillo, H., Martin, R., Cohen, J. D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121623109 · Cited by 1,666
CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
Teicher, B. A., & Fricker, S. P. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2329 · Cited by 1,449
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Liu, C., Kelnar, K., Liu, B., Chen, X., Calhoun-Davis, T., Li, H., Patrawala, L., Yan, H., Jeter, C., Honorio, S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2284 · Cited by 1,400
Targeting of CD44 eradicates human acute myeloid leukemic stem cells
Jin, L., Hope, K. J., Zhai, Q., Smadja-Joffe, F., & Dick, J. E. (2006) · Nature Medicine · doi:10.1038/nm1483 · Cited by 1,219
Beier, D., Hau, P., Proescholdt, M., Lohmeier, A., Wischhusen, J., Oefner, P. J., Aigner, L., Brawanski, A., Bogdahn, U., & Beier, C. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4180 · Cited by 1,153
MicroRNA-21 Targets the Tumor Suppressor Gene Tropomyosin 1 (TPM1)
Zhu, S., Si, M.-L., Wu, H., & Mo, Y.-Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611393200 · Cited by 1,090
Is NF-κB a good target for cancer therapy? Hopes and pitfalls
Baud, V., & Karin, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2781 · Cited by 1,061
Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44
Takaishi, S., Okumura, T., Tu, S., Wang, S. S. W., Shibata, W., Vigneshwaran, R., Gordon, S. A. K., Shimada, Y., & Wang, T. C. (2009) · Stem Cells · doi:10.1002/stem.30 · Cited by 1,039
Can we safely target the WNT pathway?
Kahn, M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4233 · Cited by 1,034
Thomas, H., & Coley, H. M. (2003) · Cancer Control · doi:10.1177/107327480301000207 · Cited by 931
Shmelkov, S. V., Butler, J. M., Hooper, A. T., Hormigo, A., Kushner, J., Milde, T., St. Clair, R., Baljevic, M., White, I., Jin, D. K., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34401 · Cited by 896
Eyes Wide Open: A Critical Review of Sphere-Formation as an Assay for Stem Cells
Pastrana, E., Silva-Vargas, V., & Doetsch, F. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.04.007 · Cited by 828
Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells
Kelly, P. N., Dakic, A., Adams, J. M., Nutt, S. L., & Strasser, A. (2007) · Science · doi:10.1126/science.1142596 · Cited by 827
Acid-Mediated Tumor Invasion: a Multidisciplinary Study
Gatenby, R. A., Gawlinski, E. T., Gmitro, A. F., Kaylor, B., & Gillies, R. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4193 · Cited by 771
Scharenberg, C. W., Harkey, M. A., & Torok-Storb, B. (2002) · Blood · doi:10.1182/blood.v99.2.507 · Cited by 770
Mechanisms of chemoresistance in cancer stem cells
Abdullah, L. N., & Chow, E. K. (2013) · Clinical and Translational Medicine · doi:10.1186/2001-1326-2-3 · Cited by 721
Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells
Chekulaeva, M., & Filipowicz, W. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.04.009 · Cited by 685
Goodison, S., Urquidi, V, & Tarin, D. (1999) · Molecular Pathology · doi:10.1136/mp.52.4.189 · Cited by 679
Chiba, T., Kita, K., Zheng, Y.-W., Yokosuka, O., Saisho, H., Iwama, A., Nakauchi, H., & Taniguchi, H. (2006) · Hepatology · doi:10.1002/hep.21227 · Cited by 664
A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors
Rubin, J. B., Kung, A. L., Klein, R. S., Chan, J. A., Sun, Y., Schmidt, K., Kieran, M. W., Luster, A. D., & Segal, R. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235846100 · Cited by 615
Gurney, A., Axelrod, F., Bond, C. J., Cain, J., Chartier, C., Donigan, L., Fischer, M., Chaudhari, A., Ji, M., Kapoun, A. M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120068109 · Cited by 614
Generation of human induced pluripotent stem cells from urine samples
Zhou, T., Benda, C., Dunzinger, S., Huang, Y., Ho, J. C., Yang, J., Wang, Y., Zhang, Y., Zhuang, Q., Li, Y., et al. (2012) · Nature Protocols · doi:10.1038/nprot.2012.115 · Cited by 614
Understanding and targeting cancer stem cells: therapeutic implications and challenges
Chen, K., Huang, Y.-H., & Chen, J.-L. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.27 · Cited by 608
Characterization of a Side Population of Cancer Cells from Human Gastrointestinal System
Haraguchi, N., Utsunomiya, T., Inoue, H., Tanaka, F., Mimori, K., Barnard, G. F., & Mori, M. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0282 · Cited by 569
Drug Resistance and Cellular Adaptation to Tumor Acidic pH Microenvironment
Wojtkowiak, J. W., Verduzco, D., Schramm, K. J., & Gillies, R. J. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200292c · Cited by 566
Regulation of Breast Cancer Stem Cell Activity by Signaling through the Notch4 Receptor
Harrison, H., Farnie, G., Howell, S. J., Rock, R. E., Stylianou, S., Brennan, K. R., Bundred, N. J., & Clarke, R. B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1681 · Cited by 543
Cancer stem cells in the development of liver cancer
Yamashita, T., & Wang, X. W. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66024 · Cited by 525
Combining two strategies to improve perfusion and drug delivery in solid tumors
Stylianopoulos, T., & Jain, R. K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318415110 · Cited by 508
Targeting Hedgehog — a Cancer Stem Cell Pathway
Merchant, A. A., & Matsui, W. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2846 · Cited by 500
Mir-34: A New Weapon Against Cancer?
Misso, G., Di Martino, M. T., De Rosa, G., Farooqi, A. A., Lombardi, A., Campani, V., Zarone, M. R., Gullà, A., Tagliaferri, P., Tassone, P., et al. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.47 · Cited by 498
Saito, Y., Kitamura, H., Hijikata, A., Tomizawa-Murasawa, M., Tanaka, S., Takagi, S., Uchida, N., Suzuki, N., Sone, A., Najima, Y., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000349 · Cited by 458
van Rhenen, A., van Dongen, G. A. M. S., Kelder, A., Rombouts, E. J., Feller, N., Moshaver, B., Walsum, M. S.-V., Zweegman, S., Ossenkoppele, G. J., & Jan Schuurhuis, G. (2007) · Blood · doi:10.1182/blood-2007-03-083048 · Cited by 439
Targeting Cancer Stem Cells through L1CAM Suppresses Glioma Growth
Bao, S., Wu, Q., Li, Z., Sathornsumetee, S., Wang, H., McLendon, R. E., Hjelmeland, A. B., & Rich, J. N. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1079 · Cited by 427
Preferential induction of apoptosis for primary human leukemic stem cells
Guzman, M. L., Swiderski, C. F., Howard, D. S., Grimes, B. A., Rossi, R. M., Szilvassy, S. J., & Jordan, C. T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252462599 · Cited by 426
Targeting the extrinsic apoptosis pathway in cancer
Ashkenazi, A. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.04.001 · Cited by 418
Targeting Notch signaling pathway in cancer: Clinical development advances and challenges
Takebe, N., Nguyen, D., & Yang, S. X. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.09.005 · Cited by 413
Current insights into the regulation of programmed cell death by NF-κB
Dutta, J., Fan, Y., Gupta, N., Fan, G., & Gélinas, C. (2006) · Oncogene · doi:10.1038/sj.onc.1209938 · Cited by 407
Therapeutic Antibody Targeting of CD47 Eliminates Human Acute Lymphoblastic Leukemia
Chao, M. P., Alizadeh, A. A., Tang, C., Jan, M., Weissman-Tsukamoto, R., Zhao, F., Park, C. Y., Weissman, I. L., & Majeti, R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2238 · Cited by 382
CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia
Hosen, N., Park, C. Y., Tatsumi, N., Oji, Y., Sugiyama, H., Gramatzki, M., Krensky, A. M., & Weissman, I. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704271104 · Cited by 379
Chang, L., Graham, P. H., Hao, J., Ni, J., Bucci, J., Cozzi, P. J., Kearsley, J. H., & Li, Y. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.407 · Cited by 377
Oncogenic and tumor suppressor functions of Notch in cancer: it’s NOTCH what you think
Lobry, C., Oh, P., & Aifantis, I. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20111855 · Cited by 356
CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway
Liang, Z., Brooks, J., Willard, M., Liang, K., Yoon, Y., Kang, S., & Shim, H. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.182 · Cited by 334
Yan, L. X., Wu, Q. N., Zhang, Y., Li, Y. Y., Liao, D. Z., Hou, J. H., Fu, J., Zeng, M. S., Yun, J. P., Wu, Q. L., et al. (2011) · Breast Cancer Research · doi:10.1186/bcr2803 · Cited by 323
Differentiation Therapy Exerts Antitumor Effects on Stem-like Glioma Cells
Campos, B., Wan, F., Farhadi, M., Ernst, A., Zeppernick, F., Tagscherer, K. E., Ahmadi, R., Lohr, J., Dictus, C., Gdynia, G., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1800 · Cited by 313
Jan, M., Chao, M. P., Cha, A. C., Alizadeh, A. A., Gentles, A. J., Weissman, I. L., & Majeti, R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100551108 · Cited by 311
Marquardt, J. U., Gomez-Quiroz, L., Arreguin Camacho, L. O., Pinna, F., Lee, Y.-H., Kitade, M., Domínguez, M. P., Castven, D., Breuhahn, K., Conner, E. A., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.018 · Cited by 309
Edris, B., Weiskopf, K., Volkmer, A. K., Volkmer, J.-P., Willingham, S. B., Contreras-Trujillo, H., Liu, J., Majeti, R., West, R. B., Fletcher, J. A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121629109 · Cited by 258
Notch signaling: switching an oncogene to a tumor suppressor
Lobry, C., Oh, P., Mansour, M. R., Look, A. T., & Aifantis, I. (2014) · Blood · doi:10.1182/blood-2013-08-355818 · Cited by 249
Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells
Kim, D., Wang, J., Willingham, S. B., Martin, R., Wernig, G., & Weissman, I. L. (2012) · Leukemia · doi:10.1038/leu.2012.141 · Cited by 249
Yen, W.-C., Fischer, M. M., Axelrod, F., Bond, C., Cain, J., Cancilla, B., Henner, W. R., Meisner, R., Sato, A., Shah, J., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2808 · Cited by 246
Song, B., Wang, C., Liu, J., Wang, X., Lv, L., Wei, L., Xie, L., Zheng, Y., & Song, X. (2010) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-29-29 · Cited by 246
Hoellenriegel, J., Zboralski, D., Maasch, C., Rosin, N. Y., Wierda, W. G., Keating, M. J., Kruschinski, A., & Burger, J. A. (2014) · Blood · doi:10.1182/blood-2013-03-493924 · Cited by 242
Wnt signaling in stem and cancer stem cells
Wend, P., Holland, J. D., Ziebold, U., & Birchmeier, W. (2010) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2010.09.004 · Cited by 237
Vaiopoulos, A. G., Kostakis, I. D., Koutsilieris, M., & Papavassiliou, A. G. (2012) · STEM CELLS · doi:10.1002/stem.1031 · Cited by 231
Kajiyama, H., Shibata, K., Terauchi, M., Ino, K., Nawa, A., & Kikkawa, F. (2008) · International Journal of Cancer · doi:10.1002/ijc.23083 · Cited by 220
Retinoid signaling regulates breast cancer stem cell differentiation
Ginestier, C., Wicinski, J., Cervera, N., Monville, F., Finetti, P., Bertucci, F., Wicha, M. S., Birnbaum, D., & Charafe-Jauffret, E. (2009) · Cell Cycle · doi:10.4161/cc.8.20.9761 · Cited by 217
Olsson, E., Honeth, G., Bendahl, P.-O., Saal, L. H., Gruvberger-Saal, S., Ringnér, M., Vallon-Christersson, J., Jönsson, G., Holm, K., Lövgren, K., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-418 · Cited by 204
NF-κB pathway inhibitors preferentially inhibit breast cancer stem-like cells
Zhou, J., Zhang, H., Gu, P., Bai, J., Margolick, J. B., & Zhang, Y. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9798-y · Cited by 201
Hassan, K. A., Wang, L., Korkaya, H., Chen, G., Maillard, I., Beer, D. G., Kalemkerian, G. P., & Wicha, M. S. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0370 · Cited by 199
CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer
Swaminathan, S. K., Roger, E., Toti, U., Niu, L., Ohlfest, J. R., & Panyam, J. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.07.014 · Cited by 196
Chao, M. P., Tang, C., Pachynski, R. K., Chin, R., Majeti, R., & Weissman, I. L. (2011) · Blood · doi:10.1182/blood-2011-02-338020 · Cited by 194
Crane, A. M., Kramer, P., Bui, J. H., Chung, W. J., Li, X. S., Gonzalez-Garay, M. L., Hawkins, F., Liao, W., Mora, D., Choi, S., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.02.005 · Cited by 193
Evolution of the cancer genome
Podlaha, O., Riester, M., De, S., & Michor, F. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.01.003 · Cited by 188
Monoclonal antibody therapy directed against human acute myeloid leukemia stem cells
Majeti, R. (2010) · Oncogene · doi:10.1038/onc.2010.511 · Cited by 176
Lou (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000530 · Cited by 175
Minderman, H., O’Loughlin, K. L., Pendyala, L., & Baer, M. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0914-3 · Cited by 170
Brechbiel, J., Miller-Moslin, K., & Adjei, A. A. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.02.003 · Cited by 167
Agliano, A., Martin‐Padura, I., Mancuso, P., Marighetti, P., Rabascio, C., Pruneri, G., Shultz, L. D., & Bertolini, F. (2008) · International Journal of Cancer · doi:10.1002/ijc.23772 · Cited by 163
Antibody Against CD44s Inhibits Pancreatic Tumor Initiation and Postradiation Recurrence in Mice
Li, L., Hao, X., Qin, J., Tang, W., He, F., Smith, A., Zhang, M., Simeone, D. M., Qiao, X. T., Chen, Z.-N., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.035 · Cited by 161
Cancer stem cells in lung cancer: Evidence and controversies
Alamgeer, M., Peacock, C. D., Matsui, W. H., Ganju, V., & Watkins, D. N. (2013) · Respirology · doi:10.1111/resp.12094 · Cited by 158
Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches
Pan, Q., Li, Q., Liu, S., Ning, N., Zhang, X., Xu, Y., Chang, A. E., & Wicha, M. S. (2015) · Stem Cells · doi:10.1002/stem.2039 · Cited by 158
Marangoni, E., Lecomte, N., Durand, L., Pinieux, G. D. B. D., Decaudin, D., Chomienne, C., Smadja‐Joffe, F., & Poupon, M. F. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604953 · Cited by 157
Liu, L., Salnikov, A. V., Bauer, N., Aleksandrowicz, E., Labsch, S., Nwaeburu, C. C., Mattern, J., Gladkich, J., Schemmer, P., Werner, J., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28583 · Cited by 149
PTEN, Stem Cells, and Cancer Stem Cells
Hill, R., & Wu, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800071200 · Cited by 145
Salvador, M. A., Wicinski, J., Cabaud, O., Toiron, Y., Finetti, P., Josselin, E., Lelièvre, H., Kraus‐Berthier, L., Depil, S., Bertucci, F., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0877 · Cited by 144
Xu, Z., Liu, S., Kang, Y., & Wang, M. (2015) · Nanoscale · doi:10.1039/c5nr00297d · Cited by 143
Dong, P., Konno, Y., Watari, H., Hosaka, M., Noguchi, M., & Sakuragi, N. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0231-0 · Cited by 141
Hypoxia Inducible Factor Pathway Inhibitors as Anticancer Therapeutics
Burroughs, S. K., Kaluz, S., Wang, D., Wang, K., Van Meir, E. G., & Wang, B. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.17 · Cited by 140
Notch1 counteracts WNT/β-catenin signaling through chromatin modification in colorectal cancer
Kim, H.-A., Koo, B.-K., Cho, J.-H., Kim, Y.-Y., Seong, J., Chang, H. J., Oh, Y. M., Stange, D. E., Park, J.-G., Hwang, D., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61216 · Cited by 139
Systemic Buffers Inhibit Carcinogenesis in TRAMP Mice
Ibrahim‐Hashim, A., Cornnell, H. H., Abrahams, D. F., Lloyd, M. C., Bui, M. M., Gillies, R. J., & Gatenby, R. A. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.03.113 · Cited by 133
Justilien, V., & Fields, A. P. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0507 · Cited by 131
CXCL12-CXCR4 axis promotes the natural selection of breast cancer cell metastasis
Sun, Y., Mao, X., Fan, C., Liu, C., Guo, A., Guan, S., Jin, Q., Li, B., Yao, F., & Jin, F. (2014) · Tumor Biology · doi:10.1007/s13277-014-1816-1 · Cited by 129
The role of hypoxia-inducible factor-2 in digestive system cancers
Zhao, J., Du, F., Shen, G., Zheng, F., & Xu, B. (2015) · Cell Death & Disease · doi:10.1038/cddis.2014.565 · Cited by 122
Angiogenesis in cancer: Anti-VEGF escape mechanisms.
Prager, G. W., Poettler, M., Unseld, M., & Zielinski, C. C. (2012) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2218-6751.2011.11.02 · Cited by 122
Shi, Y., Liu, C., Liu, X., Tang, D. G., & Wang, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090022 · Cited by 120
Role of CD44 in tumour progression and strategies for targeting
Negi, L. M. S., Talegaonkar, S., Jaggi, M., Ahmad, F. J., Iqbal, Z., & Khar, R. K. (2012) · Journal of drug targeting · doi:10.3109/1061186x.2012.702767 · Cited by 119
CD44: a validated target for improved delivery of cancer therapeutics
Ghosh, S. C., Alpay, S. N., & Klostergaard, J. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.687374 · Cited by 118
Hallett, R. M., Kondratyev, M. K., Giacomelli, A. O., Nixon, A. M. L., Girgis-Gabardo, A., Ilieva, D., & Hassell, J. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033976 · Cited by 114
MicroRNAs: regulators of oncogenesis and stemness
Papagiannakopoulos, T. Y., & Kosik, K. S. (2008) · BMC Medicine · doi:10.1186/1741-7015-6-15 · Cited by 114
TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors
Plasilova, M. L., Živný, J., Jelínek, J., Neuwirtová, R., Čermák, J., Nečas, E., Anděra, L., & Stopka, T. (2002) · Leukemia · doi:10.1038/sj.leu.2402338 · Cited by 112
Karthikeyan, S., & Hoti, S. (2015) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520615666150113103439 · Cited by 111
Han, J., Fujisawa, T., Husain, S. R., & Puri, R. K. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-173 · Cited by 109
Huang, J., Li, C., Wang, Y., Lv, H., Guo, Y., Dai, H., Wicha, M. S., Chang, A. E., & Li, Q. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.07.006 · Cited by 107
Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression
Skubitz, A. P. N., Taras, E. P., Boylan, K. L. M., Waldron, N. N., Oh, S., Panoskaltsis‐Mortari, A., & Vallera, D. A. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.05.027 · Cited by 106
Wellbrock, J., Latuske, E., Köhler, J., Wagner, K., Stamm, H., Vettorazzi, E., Vohwinkel, G., Klokow, M., Uibeleisen, R., Ehm, P. A. H., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1059 · Cited by 105
Oncogene-specific formation of chemoresistant murine hepatic cancer stem cells
Chow, E. K., Fan, L., Chen, X., & Bishop, M. J. (2012) · Hepatology · doi:10.1002/hep.25776 · Cited by 103
Blockade of SDF-1 after irradiation inhibits tumor recurrences of autochthonous brain tumors in rats
Liu, S.-C., Alomran, R., Chernikova, S. B., Lartey, F. M., Stafford, J. H., Jang, T., Merchant, M. J., Zboralski, D., Zöllner, S. K., Kruschinski, A., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not149 · Cited by 103
Oncogene-induced plasticity and cancer stem cells
Rapp, U. R., Ceteci, F., & Schreck, R. (2008) · Cell Cycle · doi:10.4161/cc.7.1.5203 · Cited by 98
Unterkircher, T., Cristofanon, S., Vellanki, S. H., Nonnenmacher, L., Karpel‐Massler, G., Wirtz, C. R., Debatin, K., & Fulda, S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0075 · Cited by 97
HIF1α Regulates mTOR Signaling and Viability of Prostate Cancer Stem Cells
Marhold, M., Tomasich, E., El‐Gazzar, A., Heller, G., Spittler, A., Horvat, R., Krainer, M., & Horak, P. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0153-t · Cited by 97
TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell population
Loebinger, M. R., Sage, E. K., Davies, D. C., & Janes, S. M. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605952 · Cited by 88
Flavonoids and Wnt/β-Catenin Signaling: Potential Role in Colorectal Cancer Therapies
Amado, N. G., Predes, D., Moreno, M. M., Carvalho, I., Mendes, F. A., & Abreu, J. G. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150712094 · Cited by 88
Epithelial–mesenchymal transition and cancer stemness: the Twist1–Bmi1 connection
Wu, K.-J., & Yang, M. (2011) · Bioscience Reports · doi:10.1042/bsr20100114 · Cited by 88
Cancer Stem Cell-Like Phenotype and Survival Are Coordinately Regulated by Akt/FoxO/Bim Pathway
Gargini, R., Cerliani, J. P., Escoll, M., Antón, I. M., & Wandosell, F. G. (2014) · Stem Cells · doi:10.1002/stem.1904 · Cited by 86
Christgen, M., Ballmaier, M., Bruchhardt, H., von Wasielewski, R., Kreipe, H. H., & Lehmann, U. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9570-y · Cited by 84
Targeting the Hedgehog signaling pathway for cancer therapy
Li, Y., Maitah, M. Y., Ahmad, A., Kong, D., Bao, B., & Sarkar, F. H. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.617367 · Cited by 81
Zhao, Y. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i1.112 · Cited by 78
The opposing roles of NOTCH signalling in head and neck cancer: a mini review
Yap, L. F., Lee, D., Khairuddin, A. N. M., Pairan, M., Puspita, B., Siar, C. H., & Paterson, I. C. (2015) · Oral Diseases · doi:10.1111/odi.12309 · Cited by 75
Overcoming multidrug resistance with nanomedicines
Ganoth, A., Merimi, K. C., & Peer, D. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.960920 · Cited by 74
Epithelial ovarian cancer stem cells: underlying complexity of a simple paradigm
Garson, K., & Vanderhyden, B. C. (2014) · Reproduction · doi:10.1530/rep-14-0234 · Cited by 73
Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis
Wong, D., Kandagatla, P., Korz, W., & Chinni, S. R. (2014) · BMC Urology · doi:10.1186/1471-2490-14-12 · Cited by 72
Shi, S., Zhong, Z., Liu, J., Zhang, Z., Sun, X., & Gong, T. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0514-6 · Cited by 68
IL-24 Inhibits Lung Cancer Cell Migration and Invasion by Disrupting The SDF-1/CXCR4 Signaling Axis
Panneerselvam, J., Jin, J., Shanker, M., Lauderdale, J., Bates, J., Wang, Q., Zhao, Y. D., Archibald, S. J., Hubin, T. J., & Ramesh, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122439 · Cited by 68
Xu, Z., Wang, D., Xu, S. H., Liu, X., Zhang, X., & Zhang, H. (2013) · Chemistry - An Asian Journal · doi:10.1002/asia.201301030 · Cited by 66
Wang, Y., Zhang, Y., Kathawala, R. J., & Chen, Z. (2014) · Cancers · doi:10.3390/cancers6041925 · Cited by 66
Hedgehog signaling in cancer stem cells: a focus on hematological cancers
Campbell, V. L., & Copland, M. (2015) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s58613 · Cited by 64
Chikamatsu, K., Ishii, H., Murata, T., Sakakura, K., Shino, M., Toyoda, M., Takahashi, K., & Masuyama, K. (2013) · Cancer Science · doi:10.1111/cas.12271 · Cited by 64
Wnt blockers inhibit the proliferation of lung cancer stem cells
Han, B., Zhang, X., Lou, Y., Zheng, X., Wang, H., Su, J., & Dong, Q. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s76602 · Cited by 62
Duru, N., Candas, D., Jiang, G., & Li, J. J. (2013) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-013-1494-1 · Cited by 61
Canonical and Noncanonical Hedgehog/GLI Signaling in Hematological Malignancies
Aberger, F., Kern, D., Greil, R., & Hartmann, T. N. (2012) · Vitamins and hormones · doi:10.1016/b978-0-12-394622-5.00002-x · Cited by 60
Huang, F.-F., Zhang, L., Wu, D., Yuan, X., Chen, F., Zeng, H., Yu, Y., & Zhao, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088298 · Cited by 54
Gu, D., Liu, H., Su, G. H., Zhang, X., Chin-Sinex, H., Hanenberg, H., Mendonca, M. S., Shannon, H. E., Chiorean, E. G., & Xie, J. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1030 · Cited by 53
Cisplatin and TRAIL enhance breast cancer stem cell death
Reddy, K. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1085 · Cited by 49
Dong, Y., Han, Q., Zou, Y., et al. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1401-0 · Cited by 47
Effective inhibition of metastases and primary tumor growth with CTCE-9908 in esophageal cancer
Drenckhan, A., Kurschat, N., Dohrmann, T., Raabe, N., Koenig, A. M., Reichelt, U., Kaifi, J. T., Izbicki, J. R., & Gros, S. J. (2012) · Journal of Surgical Research · doi:10.1016/j.jss.2012.09.035 · Cited by 46
Petrelli, A., Carollo, R., Cargnelutti, M., Iovino, F., Callari, M., Cimino, D., Todaro, M., Mangiapane, L. R., Giammona, A., Cordova, A., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2962 · Cited by 45
Imai, Y., Yoshimori, M., Fukuda, K., Yamagishi, H., & Ueda, Y. (2012) · Oncology Reports · doi:10.3892/or.2012.1724 · Cited by 45
Bladder Cancer Stem Cells: Biological and Therapeutic Perspectives
Jinesh, G. G., Willis, D. L., & Kamat, A. M. (2014) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x08666131113123051 · Cited by 45
Osanyingbemi-Obidi, J., Dobromilskaya, I., Illei, P. B., Hann, C. L., & Rudin, C. M. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0286 · Cited by 45
MicroRNAs, stem cells and cancer stem cells
Garg, M. (2012) · World Journal of Stem Cells · doi:10.4252/wjsc.v4.i7.62 · Cited by 43
Evaluation of a CXCR4 antagonist in a xenograft mouse model of inflammatory breast cancer
Singh, B., Cook, K. R., Martín, C., Huang, E. H., Mosalpuria, K., Krishnamurthy, S., Cristofanilli, M., & Lucci, A. (2010) · Clinical & Experimental Metastasis · doi:10.1007/s10585-010-9321-4 · Cited by 43
Matsushita, H., Scaglioni, P. P., Bhaumik, M., Rego, E. M., Cai, L. F., Majid, S. M., Miyachi, H., Kakizuka, A., Miller, W. H., & Pandolfi, P. P. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050616 · Cited by 42
Genomic instability en route to and from cancer stem cells
Li, L., Borodyansky, L., & Yang, Y. (2009) · Cell Cycle · doi:10.4161/cc.8.7.8041 · Cited by 41
Masuko, K., Okazaki, S., Satoh, M., Tanaka, G., Ikeda, T., Torii, R., Ueda, E., Nakano, T., Danbayashi, M., Tsuruoka, T., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029728 · Cited by 40
Zuo, M., Rashid, A., Churi, C. R., Vauthey, J.-N., Chang, P., Li, Y., Hung, M., Li, D., & Javle, M. M. (2015) · British Journal of Cancer · doi:10.1038/bjc.2014.625 · Cited by 40
Review Immunotargeting of cancer stem cells
Kwiatkowska-Borowczyk, E. P., Gąbka-Buszek, A., Jankowski, J., & Mackiewicz, A. A. (2015) · Współczesna Onkologia · doi:10.5114/wo.2014.47129 · Cited by 40
Burkhardt, J., Hofstetter, C. P., Santillán, A., Shin, B. J., Foley, C. P., Ballon, D., Gobin, Y. P., & Boockvar, J. A. (2012) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2012.03.012 · Cited by 39
Stratford, E. W., Bostad, M., Castro, R., Skarpen, E., Berg, K., Høgset, A., Myklebost, O., & Selbo, P. K. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.04.033 · Cited by 37
Therapeutics formulated to target cancer stem cells: Is it in our future?
Clayton, S. B., & Mousa, S. A. (2011) · Cancer Cell International · doi:10.1186/1475-2867-11-7 · Cited by 36
NOTCH Mutations: Multiple Faces in Human Malignancies
Mao, L. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0063 · Cited by 35
Gillespie, D. L., Aguirre, M. T., Ravichandran, S., Leishman, L. L., Berrondo, C., Gamboa, J. T., Wang, L., King, R., Wang, X., Tan, M., et al. (2014) · Journal of neurosurgery · doi:10.3171/2014.10.jns132363 · Cited by 29
Singla, A. K., Downey, C. M., Bebb, G. D., & Jirik, F. R. (2015) · Oncoscience · doi:10.18632/oncoscience.117 · Cited by 29
Targeting the Hedgehog Pathway
Cohen, D. J. (2012) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2012.01.005 · Cited by 23
Surface markers of hepatocellular cancer stem cells and their clinical potential
Feng, D., Wang, N., HU, J., & Li, W. (2014) · Neoplasma · doi:10.4149/neo_2014_061 · Cited by 19
(2003) · PubMed
Cited by
Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
Phi, L. T. H., Sari, I. N., Yang, Y.-G., Lee, S.-H., Jun, N., Kim, K. S., Lee, Y. K., & Kwon, H. Y. (2018) · Stem Cells International · doi:10.1155/2018/5416923 · Cited by 994
Nunes, A. S., Barros, A. S., Costa, E. C., Moreira, A. F., & Correia, I. J. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.26845 · Cited by 721
Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy
Chen, W., Dong, J., Haiech, J., Kilhoffer, M.-C., & Zeniou, M. (2016) · Stem Cells International · doi:10.1155/2016/1740936 · Cited by 402
Cancer stem cells: The root of tumor recurrence and metastases
Peitzsch, C., Tyutyunnykova, A., Pantel, K., & Dubrovska, A. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.02.011 · Cited by 372
Battling Chemoresistance in Cancer: Root Causes and Strategies to Uproot Them
Ramos, A., Sadeghi, S., & Tabatabaeian, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179451 · Cited by 289
Metadata
- Authors
- Dragu, D. L.
- Venue
- World Journal of Stem Cells
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2015
- Volume
- 7
- Issue
- 9
- Pages
- 1185
- ISSN
- 1948-0210 (ISSN-L)
- OpenAlex
- W2181400744
- Cited by
- 257
- References
- 159
- FWCI
- 12.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.